Is Starlink Set For The Largest IPO In History?

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

Michelle L. Basil net worth and biography

Michelle Basil Biography and Net Worth

EVP of Haemonetics

Michelle Basil joined Haemonetics in March 2017 as Executive Vice President, General Counsel. She is responsible for Haemonetics' Legal, Compliance, Corporate Development and Corporate Audits and Controls groups. Prior to joining Haemonetics, Ms. Basil was a Partner and Chair of the Life Sciences Practice Group at the Boston-based law firm Nutter, McClennen & Fish where she was legal counsel to public and private companies and their investors, principally in the life sciences and medical technology industries. At Nutter, Ms. Basil’s practice focused on corporate and securities law, including mergers and acquisitions, strategic collaborations, capital markets transactions, corporate governance and other matters affecting publicly traded companies and their officers and directors. Ms. Basil is admitted to the bar in Massachusetts and holds both a Bachelor of Arts and a Juris Doctor from the University of California at Berkeley.

What is Michelle L. Basil's net worth?: The estimated net worth of Michelle L. Basil is at least $2.46 million as of May 29th, 2024. Ms. Basil owns 31,257 shares of Haemonetics stock worth more than $2,462,114 as of December 19th. This net worth estimate does not reflect any other investments that Ms. Basil may own. Additionally, Ms. Basil receives a salary of $1,260,000.00 as EVP at Haemonetics. Learn More about Michelle L. Basil's net worth.
How old is Michelle L. Basil?: Ms. Basil is currently 52 years old. There are 5 older executives and no younger executives at Haemonetics. The oldest executive at Haemonetics is Mr. Josep Lluis Llorens, Executive Vice President of Global Manufacturing & Supply Chain, who is 62 years old. Learn More on Michelle L. Basil's age.
What is Michelle L. Basil's salary?: As the EVP of Haemonetics Co., Ms. Basil earns $1,260,000.00 per year. The highest earning executive at Haemonetics is Mr. Christopher A. Simon, CEO, President & Director, who commands a salary of $3,260,000.00 per year. Learn More on Michelle L. Basil's salary.
How do I contact Michelle L. Basil?: The corporate mailing address for Ms. Basil and other Haemonetics executives is 125 Summer Street, Boston MA, 02110. Haemonetics can also be reached via phone at (781) 848-7100 and via email at [email protected]. Learn More on Michelle L. Basil's contact information.
Has Michelle L. Basil been buying or selling shares of Haemonetics?: Michelle L. Basil has not been actively trading shares of Haemonetics during the last quarter. Most recently, Michelle L. Basil sold 12,990 shares of the business's stock in a transaction on Wednesday, May 29th. The shares were sold at an average price of $88.08, for a transaction totalling $1,144,159.20. Following the completion of the sale, the executive vice president now directly owns 31,257 shares of the company's stock, valued at $2,753,116.56. Learn More on Michelle L. Basil's trading history.
Who are Haemonetics' active insiders?: Haemonetics' insider roster includes Michelle Basil (EVP), William Burke (CFO), Dan Goldstein (VP), Mark Kroll (Director), Anila Lingamneni (EVP), Josep Llorens (EVP), Richard Meelia (Director), Laurie Miller (SVP), Jacqueline Scanlan (SVP), Christopher Simon (CEO, President & Director), and Stewart Strong (Insider). Learn More on Haemonetics' active insiders.
Are insiders buying or selling shares of Haemonetics?: During the last twelve months, insiders at the medical instruments supplier sold shares 9 times. They sold a total of 33,828 shares worth more than $3,031,094.99. The most recent insider tranaction occured on July, 26th when insider Stewart W Strong sold 4,312 shares worth more than $393,038.80. Insiders at Haemonetics own 1.8% of the company. Learn More about insider trades at Haemonetics.
Information on this page was last updated on 7/26/2024.

Michelle L. Basil Insider Trading History at Haemonetics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/29/2024	Sell	12,990	$88.08	$1,144,159.20	31,257
10/24/2022	Sell	180	$80.39	$14,470.20	32,455
9/19/2022	Sell	11,448	$78.36	$897,065.28	32,635
9/15/2022	Sell	33,798	$77.89	$2,632,526.22	35,395
6/13/2022	Sell	277	$62.60	$17,340.20	40,635
10/25/2021	Sell	120	$71.93	$8,631.60
6/14/2021	Sell	195	$59.87	$11,674.65
6/7/2021	Sell	442	$55.09	$24,349.78
5/17/2021	Sell	204	$55.97	$11,417.88
10/23/2020	Sell	181	$106.58	$19,290.98
6/16/2020	Sell	24,217	$89.56	$2,168,874.52
6/12/2020	Sell	203	$89.29	$18,125.87
6/8/2020	Sell	687	$97.03	$66,659.61
3/9/2020	Sell	395	$98.00	$38,710.00
10/8/2019	Sell	8,883	$122.34	$1,086,746.22
6/7/2019	Sell	7,187	$103.49	$743,782.63
3/7/2019	Sell	391	$83.57	$32,675.87
6/7/2018	Sell	457	$92.73	$42,377.61
3/6/2018	Sell	389	$72.23	$28,097.47

Michelle L. Basil Buying and Selling Activity at Haemonetics

Haemonetics Company Overview

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system and Donor360 app. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot-inducing properties of collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $78.77

$78.26

$82.27

50 Day Range

MA: $81.32

$71.15

$93.38

2 Week Range

Now: $78.77

$70.25

$97.97

Volume

518,622 shs

Average Volume

551,348 shs

Market Capitalization

$3.96 billion

P/E Ratio

32.68

Dividend Yield

N/A

Beta

0.38

Is Starlink Set For The Largest IPO In History?

From Paradigm Press | Ad

Click here now for the urgent details.

Michelle Basil Biography and Net Worth

What is Michelle L. Basil's net worth?

How old is Michelle L. Basil?

What is Michelle L. Basil's salary?

How do I contact Michelle L. Basil?

Has Michelle L. Basil been buying or selling shares of Haemonetics?

Who are Haemonetics' active insiders?

Are insiders buying or selling shares of Haemonetics?